SCHEMBL4229509

SCHEMBL4229509

Cn1c(=O)[nH]c(=O)c2c1c(C#N)c(N1CCN(C(=O)OC(C)(C)C)CC1)n2Cc1ccccc1

nearest known ligand 0.44

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
DPP4 P27487 6/20 0.44
KCNH2 Q12809 2/20 0.44
KMT2A Q03164 2/20 0.42
GAA P10253 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
POLB P06746 1/20 0.42
ACHE P22303 1/20 0.41
ALDH1A1 P00352 2/20 0.41
HTT P42858 2/20 0.41
NPSR1 Q6W5P4 2/20 0.41
GPR119 Q8TDV5 2/20 0.41
MEN1 O00255 1/20 0.41
TSHR P16473 1/20 0.41
PARP1 P09874 2/20 0.40
PARP2 Q9UGN5 2/20 0.40
HTR6 P50406 1/20 0.39
KIT P10721 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4220111 0.97 DPP4 (0.46) DPP4KCNH2KMT2AGAAL3MBTL1
SCHEMBL13780233 0.84 DPP4 (0.61) DPP4KCNH2GAAACHEALDH1A1
SCHEMBL8240875 0.82 DPP4 (0.62) DPP4KCNH2KMT2APOLBALDH1A1
SCHEMBL4220248 0.80 DPP4 (0.40) DPP4KCNH2GPR119
SCHEMBL5719159 0.80 POLB (0.67) DPP4KMT2AGAAL3MBTL1POLB
SCHEMBL4221261 0.80 DPP4 (0.44) DPP4KCNH2KMT2AGPR119MEN1
SCHEMBL4224792 0.77 DPP4 (0.47) DPP4KCNH2
SCHEMBL4226218 0.76 DPP4 (0.68) DPP4KCNH2
SCHEMBL13780503 0.73 KMT2A (0.53) DPP4KMT2AL3MBTL1POLBALDH1A1
SCHEMBL4224842 0.73 KMT2A (0.53) DPP4KMT2AL3MBTL1POLBALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090192138-A1 COMPOUNDS BAESCHLIN DANIEL KASPAR 2009-07-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090192138-A1 COMPOUNDS DPP4, DPP3, DPP8 DPP4 1/4885KCNH2 1859/4885KMT2A 2541/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.